Roche's $1.25B investment in U.S. facilities boosts drug manufacturing and diabetes tech, creating thousands of jobs.

Roche Group said on Monday that it plans to invest more than $700 million in a new drug manufacturing facility in North ...

Genentech, a member of the Roche Group (SIX: RO, ROG; OTCQX: RHHBY), announced today plans to invest more than $700 million ...

Prolec-GE Waukesha, Inc., one of the nation's largest manufacturers of power transformers, is planning to build a second ...

Genentech plans to invest $700 million in a new facility in Holly Springs, North Carolina, creating 420 jobs and joining the ...

More than $13 million in incentives from North Carolina are pledged to a biotech company making a $700 million investment, a ...

Genentech, a member of the Roche Group, will create 400 jobs with a new biotechnology facility in Holly Springs, Wake County, ...

The project could eventually add more than 400 manufacturing jobs and over 1,500 construction jobs during site development.

The commitment is part of Roche’s recently announced $50 billion investment in the U.S., but a company spokesperson said that ...

Genentech, considered one of the biotech industry’s founding companies, plans to build a $700 million, 700,000-square-foot ...

Roche Group said on Monday that it plans to invest more than $700 million in a new drug manufacturing facility in Holly ...

HOLLY SPRINGS, N.C. -- Genentech, a leading biotechnology company based in San Francisco, is set to build a $700 million ...